PMED - Preço Médico TUSS CBHPM

48
PMED - Preço Médico TUSS CBHPM
PMED - Preço Médico TUSS CBHPM is an iOS app from OAZEZ SOFTWARE E TECNOLOGIA LTDA in the Education category, currently rated 4.5★ across 4 ratings. Initial signal reads as no scraped reviews yet: judgment based on metadata only.
Quality Score is 48: Emerging (early traction worth watching). For a Education app, that means early traction worth watching. The full BU Investment Matrix below scores 8 dimensions including monetisation, growth, and operational risk.
Track changes month-over-month in the Performance section below: live snapshot history and revenue forecast included.
- Title & subtitle keyword fit
- Description hook & conversion structure
- Screenshots, ratings, reviews strategy
📊 Performance Tracking LIVE
Synthetic estimate. Inputs: category complexity, file size, screen count, monetization layer, platform reach, age × team-size proxy. Calibrated against 2024-2026 indie-agency rate surveys. Full math + source list on /methodology.
| 🧱MVP baseline (design + 1-store ship) | +$28K |
| 📱5 unique screens × $4.5K | +$22K |
| 📦Asset bundle (57 MB) | +$2K |
| ⚙Education complexity ×1.20 | +$10K |
| ⚙13.1y maintenance × ~1-person team | +$78K |
Heuristic guess from app bundle size, category, store description signals, and release-date stack era. Bumetric does not disassemble binaries — for binary-level certainty you would need an SDK intelligence tool or the manifest itself. Reasoning chain on the right. Full ruleset on /methodology.
| 📦App bundle size | 57 MB |
| 🏷Category context | Education |
| 📦Small-mid iOS bundle | → Native Swift / UIKit (pre-2020 era) |
Heuristic risk score from time-since-last-update + ratings velocity proxy + Editor's Choice / curated featuring signals. Calibrated against 2024-2025 app-store ranking decay reports. Not a guarantee — a quiet app with a healthy codebase looks the same as an abandoned one until something breaks. Full math on /methodology.
| 📅4 months since last update | Slowing cadence |
| 👥Small user base (4 ratings) + 13.1y old | +10% (solo-project pattern) |
How we forecast this revenue
MEDIUM CONFIDENCEBU Investment Matrix
Pre-traction · 34/100INDIE TIERFREE (NO MONETIZATION)limited signal- 💰 Revenue: Modest — $489 - $3060/mo · INDIE tier · medium confidence, trajectory unclear.
- ⭐ Quality: 4.5★ across 4 reviews — weak — significant quality concerns.
- 📍 Market: Not yet charting in any of the 9 monitored markets.
- 📈 Growth: Insufficient signal to assess trajectory.
- ⚠️ Risk: Moderate — rating drift -1.74 ★ (recent 50 vs lifetime).
💰 Forecast Revenue / mo
MODEL| Paid app ($4.99)METRIC | +$2,800 | |
| Excellent rating (4.5★)METRIC | +$2,200 | |
| Mature app (13y old)METRIC | +$1,500 | |
| Single-language (English only)METRIC | −$400 | |
| Pre-traction phase (4 ratings)METRIC | −$300 |
📈 Reviews Growth
LIVE⭐ Rating Trend
LIVE📝 About this app
Consultar preços de honorários e procedimentos médicos nas tabelas CBHPM, AMB e TUSS nunca foi tão fácil e rápido como com o PMED.
Nosso aplicativo é o número 1 em soluções para Medicina!
Com o PMED, você pode calcular rapidamente o valor de procedimentos utilizando as variáveis CH, FILME, UCO, PORTE, PORTE ANESTÉSICO e Número de Auxiliares, conforme cada tabela. Personalize os cálculos ajustando parâmetros como VIA DE ACESSO e TÉCNICA UTILIZADA para obter resultados ainda mais precisos.… View full description on the official store →
🆕 What's New · v1.17.35
Voice of Customer
Based on 50 reviews across 1 marketsTech & Domain Intel — youtube.com
- Mail provider
- Google Workspace
- Tech stack
- Meta (Facebook) Ads · Google Workspace
Multi-Country Performance
Available in 7 of 9 monitored markets| Market | Rating | Reviews | Current version |
|---|---|---|---|
| 🇧🇷 BR | 4.19087★ | 241 | 4.19087★ this version |
| 🇩🇪 DE | 0★ | 0 | — |
| 🇫🇷 FR | 0★ | 0 | — |
| 🇬🇧 GB | 0★ | 0 | — |
| 🇮🇳 IN | 0★ | 0 | — |
| 🇯🇵 JP | 0★ | 0 | — |
| 🇺🇸 US | 4.5★ | 4 | 4.5★ this version |
Track this app’s revenue
FREEProfile & Insights
Identification
- App name
- PMED - Preço Médico TUSS CBHPM
- Developer
- OAZEZ SOFTWARE E TECNOLOGIA LTDA
- Bundle ID
- br.com.oazez.pmed
- App Store URL
- Open in App Store
- Category
- Education
- Content rating
- 4+
- Languages
- EN
Company
- Website
- Not found
- Tagline
- YouTube
- Description
- Auf YouTube findest du die angesagtesten Videos und Tracks. Außerdem kannst du eigene Inhalte hochladen und mit Freunden oder gleich der ganzen Welt teilen.
- Founded
- Not found
- HQ / Address
- Not found
- Employees
- Not found
- Logo
- Available
Revenue
- Verified revenue / mo
- Not found
- AI revenue estimate / mo
- Not found
- AI annual estimate
- Not found
- ML model estimate / mo
- $144/mo
- Top-grossing rank
- Outside top 100 in US Education
- All-time revenue
- Not found
- Pricing
- Not found
Founder
Funding
Press & Links
Contacts & Socials
- Socials
- facebook facebook.com/youtube/?ref=br_r · instagram instagram.com/youtube · twitter twitter.com/YouTube · youtube tv.youtube.com/learn/nflsundayticket
- Not found
- Phone
- Not found
- Contact page
- youtube.com/t/contact_us
- About page
- youtube.com/about
📈Ratings growth4 ratings+33% lifetimeShow 3-year history estimate ▾
📝 Description
95
❓ Frequently Asked Questions
Who is the author of The ?
The author is , a prominent figure in the study of occult philosophy and esoteric traditions.
What is the main theme of the book?
The main theme is the esoteric interpretation of the Book of Revelation, focusing on the mystical and symbolic meanings hidden within the text.
Why is this book important for modern esoteric seekers?
This book is important because it bridges ancient wisdom with contemporary spiritual practices, providing valuable insights into the esoteric traditions that have influenced Western spirituality.
Why low confidence: only 4 ratings · no founder-verified revenue (model estimate only) · revenue figure is directional only.
PMED - Preço Médico TUSS CBHPM is a very early-stage iOS app in the education space with weak public traction — only 4 ratings, no founder-verified MRR, and not ranked in any monitored grossing chart. The app appears to be monetised, but public signals are too sparse for a precise revenue estimate.
Bottom line: treat all revenue, audience and acquisition-value numbers on this page as directional only — not founder-verified facts.




